Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)

NCT02256553 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Seasonal

Interventions

BIOLOGICAL: MK-3641 12 Amb a 1-U (short ragweed extract)
BIOLOGICAL: MK-7243 2800 BAU (Timothy grass extract)
DRUG: Rescue Medication

Sponsor

ALK-Abelló A/S